Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Gatmem1flox/Cya
Common Name:
Gatm-flox
Product ID:
S-CKO-13499
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Gatm-flox
Strain ID
CKOCMP-67092-Gatm-B6J-VA
Gene Name
Gatm
Product ID
S-CKO-13499
Gene Alias
1810003P21Rik; AT
Background
C57BL/6JCya
NCBI ID
67092
Modification
Conditional knockout
Chromosome
2
Phenotype
MGI:1914342
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Gatmem1flox/Cya mice (Catalog S-CKO-13499) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028624
NCBI RefSeq
NM_025961
Target Region
Exon 3
Size of Effective Region
~1.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Gatm, also known as glycine amidinotransferase or AGAT, is the rate-limiting enzyme in the creatine biosynthesis pathway. Creatine synthesis involves a series of reactions where Gatm, along with guanidinoacetate N-methyltransferase (GAMT), synthesizes creatine from arginine, glycine, and S-Adenosyl methionine [4]. Creatine metabolism is important for energy homeostasis in various tissues, and Gatm-mediated creatine synthesis occurs locally throughout the mammalian body, including in oligodendrocytes of the brain [4].

In cancer research, Gatm has been shown to play significant roles. In orthotopic mouse models, upregulation of Gatm in liver metastases promotes colorectal and breast cancer metastasis. Dietary creatine uptake or Gatm-mediated de novo synthesis enhances cancer metastasis by upregulating Snail and Slug expression via MPS1-activated Smad2 and Smad3 phosphorylation, and Gatm knockdown suppresses cancer metastasis and improves mouse survival [1]. In FLT3-ITD-mutant acute myeloid leukemia, FLT3-ITD activates the STAT5 signaling pathway, upregulating Gatm expression. Pharmacologic FLT3-ITD inhibition or genetic GATM knockdown reduces intracellular creatinine levels, leading to decreased cell proliferation and increased apoptosis in mutant cell lines, suggesting that targeting Gatm could be a therapeutic strategy [3]. In pancreatic cancer, high GATM expression is positively correlated with advanced N stage, and GATM knockdown reduces intracellular guanidinoacetic acid (GAA) levels, suppresses epithelial-mesenchymal transition (EMT), and inhibits liver metastasis [5]. In obesity-driven breast cancer, Gatm in adipocytes is required for obesity-driven tumor progression, and deletion of Gatm in adipocytes attenuates tumor growth [6].

In summary, Gatm is crucial for creatine biosynthesis, which has far-reaching implications in energy-related biological processes. Through gene-knockout (KO) and conditional-knockout (CKO) mouse models, research has revealed its important roles in cancer metastasis and tumor progression, highlighting its potential as a therapeutic target in cancer treatment. Additionally, studies on Gatm polymorphism suggest its role in statin-induced myopathy and chronic kidney disease, further expanding its significance in different disease areas [2,7].

References:
1. Zhang, Liwen, Zhu, Zijing, Yan, Huiwen, Chen, Gang, Bu, Pengcheng. 2021. Creatine promotes cancer metastasis through activation of Smad2/3. In Cell metabolism, 33, 1111-1123.e4. doi:10.1016/j.cmet.2021.03.009. https://pubmed.ncbi.nlm.nih.gov/33811821/
2. Liu, Mengyuan, Fan, Fangfang, Zhang, Yan, Li, Jianping. 2020. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis. In European journal of clinical pharmacology, 77, 349-357. doi:10.1007/s00228-020-03019-3. https://pubmed.ncbi.nlm.nih.gov/33051696/
3. Zhang, Yuan, Newsom, Kimberly J, Zhang, Mei, Kelley, Jeffry S, Starostik, Petr. 2021. GATM-Mediated Creatine Biosynthesis Enables Maintenance of FLT3-ITD-Mutant Acute Myeloid Leukemia. In Molecular cancer research : MCR, 20, 293-304. doi:10.1158/1541-7786.MCR-21-0314. https://pubmed.ncbi.nlm.nih.gov/34635505/
4. Baker, Steven Andrew, Gajera, Chandresh R, Wawro, Adam M, Corces, M Ryan, Montine, Thomas J. 2021. GATM and GAMT synthesize creatine locally throughout the mammalian body and within oligodendrocytes of the brain. In Brain research, 1770, 147627. doi:10.1016/j.brainres.2021.147627. https://pubmed.ncbi.nlm.nih.gov/34418357/
5. Yang, Jinshou, Ren, Bo, Ren, Jie, You, Lei, Zhao, Yupei. 2023. Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications. In Journal of experimental & clinical cancer research : CR, 42, 155. doi:10.1186/s13046-023-02698-x. https://pubmed.ncbi.nlm.nih.gov/37370109/
6. Maguire, Olivia A, Ackerman, Sarah E, Szwed, Sarah K, Kazak, Lawrence, Cohen, Paul. 2021. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. In Cell metabolism, 33, 499-512.e6. doi:10.1016/j.cmet.2021.01.018. https://pubmed.ncbi.nlm.nih.gov/33596409/
7. Liu, Bin, Gao, Xin, Teng, Haolin, Gao, Baoshan, Li, Faping. 2024. Association between GATM gene polymorphism and progression of chronic kidney disease: a mitochondrial related genome-wide Mendelian randomization study. In Scientific reports, 14, 20346. doi:10.1038/s41598-024-68448-x. https://pubmed.ncbi.nlm.nih.gov/39284843/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest